Cullinan Therapeutics, Inc. (CGEM) vs Jade Biosciences, Inc. (JBIO)
Cullinan Therapeutics, Inc. and Jade Biosciences, Inc. are both Biotechnology companies. Cullinan Therapeutics, Inc. and Jade Biosciences, Inc. are of similar size ($992.4M and $936.8M). Across the 8 metrics below, Jade Biosciences, Inc. leads on 7 and Cullinan Therapeutics, Inc. on 1.
Valuation
Profitability
| Metric | CGEM | JBIO | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (50.30%) | (39.27%) | (57.72%) |
| Return on assets | (46.30%) | (36.19%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack